3Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York, Springer-Vertig,2002.
4Karl RC, Schreiber R, Boulware D, et al. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy[J]. Ann Surg,2000,231,635-643
5Bailey S, Bull D, Harpole D, et al. Outcomes after esophagectomy: a ten-year prospective cohort[J]. Ann Thorac Surg,2003,75:217-222
6Avendano C, Flume P, Silvestri G, et al. Pulmonary complications after esophagectomy[J]. Ann Thorac Surg,2002,73(3):922-926
4Takahashi T,Osanai S,Nakano H,et al.Doxapram stimulates the carotid body via a different mechanism than hypoxic chemotransduction[J].Respir Physiol Neurobiol,2005,147(1):1-9.
5Benard M,Boutroy M J,Glorieux I,et al.Determinants of doxapram utilization:a survey of practice in the French Neonatal and Intensive Care Units[J].Arch Pediatr,2005,12(2):151-155.
6Gomersall C D,Joynt G M,Freebairn R C,et al.Oxygen therapy for hypercapnic patients with chronic obstructive pulmonary disease and acute respiratory failure:a randomized,controlled pilot study[J].Crit Care Med,2002,30(1):113-116.
7Wu C C,Mok M S,Chen J Y,et al.Doxapram shortens recovery following sevoflurane anesthesia[J].Can J Anaesth,2006,53(5):456-460.
